A change in the study evaluation paradigm reveals that larynx preservation compromises survival in T4 laryngeal cancer patients
Larynx preservation (LP) is recommended for up to low-volume T4 laryngeal cancer as an evidence-based treatment option that does not compromise survival. However, a reevaluation of the current literature raises questions regarding whether there is indeed reliable evidence to support larynx preservat...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
1 September 2017
|
| In: |
BMC cancer
Year: 2017, Volume: 17 |
| ISSN: | 1471-2407 |
| DOI: | 10.1186/s12885-017-3608-7 |
| Online Access: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1186/s12885-017-3608-7 Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s12885-017-3608-7 
|
| Author Notes: | Gerhard Dyckhoff, Peter K. Plinkert and Heribert Ramroth |
| Summary: | Larynx preservation (LP) is recommended for up to low-volume T4 laryngeal cancer as an evidence-based treatment option that does not compromise survival. However, a reevaluation of the current literature raises questions regarding whether there is indeed reliable evidence to support larynx preservation for T4 tumor patients. |
|---|---|
| Item Description: | Gesehen am 21.09.2017 |
| Physical Description: | Online Resource |
| ISSN: | 1471-2407 |
| DOI: | 10.1186/s12885-017-3608-7 |